GLASS; David Jonathan
Patent Applications and Registrations
Patent applications and USPTO patent grants for GLASS; David Jonathan.The latest application filed is for "rapamycin derivatives".
- GLASS; David Jonathan - Cortland Manor NY
- Glass; David Jonathan - Cambridge MA
- GLASS; David Jonathan - Cortlandt Manor NY
| Patent | Date |
|---|---|
| Rapamycin Derivatives App 20220242878 - BONAZZI; Simone ; et al. | 2022-08-04 |
| Isothiazolidine 1,1-dioxide And 1,4-butan Sultone Containing Rapamycin Derivatives And Uses Thereof App 20220202787 - Bonazzi; Simone ; et al. | 2022-06-30 |
| Rapamycin Derivatives App 20220064185 - Bonazzi; Simone ; et al. | 2022-03-03 |
| Treatment Of Cancer Using Humanized Anti-bcma Chimeric Antigen Receptor App 20220064316 - Brogdon; Jennifer ; et al. | 2022-03-03 |
| Anti-BCMA chimeric antigen receptor Grant 11,084,880 - Brogdon , et al. August 10, 2 | 2021-08-10 |
| Biomarkers Predictive Of Therapeutic Responsiveness To Chimeric Antigen Receptor Therapy And Uses Thereof App 20210172020 - Bedoya; Felipe ; et al. | 2021-06-10 |
| Treatment Of Cancer Using A Cd123 Chimeric Antigen Receptor App 20210002377 - Brogdon; Jennifer ; et al. | 2021-01-07 |
| Novel Rapamycin Derivatives App 20200392159 - BONAZZI; Simone ; et al. | 2020-12-17 |
| Methods For B Cell Preconditioning In Car Therapy App 20200339651 - Brogdon; Jennifer ; et al. | 2020-10-29 |
| Rapamycin derivatives Grant 10,800,793 - Bonazzi , et al. October 13, 2 | 2020-10-13 |
| Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof Grant 10,774,388 - Bedoya , et al. Sept | 2020-09-15 |
| Treatment Of Cancer Using A Cll-1 Chimeric Antigen Receptor App 20200215171 - Brogdon; Jennifer ; et al. | 2020-07-09 |
| Treatment of cancer using a CD123 chimeric antigen receptor Grant 10,703,819 - Brogdon , et al. | 2020-07-07 |
| Treatment Of Cancer Using Anti-cd19 Chimeric Antigen Receptor App 20190388471 - June; Carl H. ; et al. | 2019-12-26 |
| Regulatable Chimeric Antigen Receptor App 20190263914 - Brogdon; Jennifer ; et al. | 2019-08-29 |
| Treatment Of Cancer Using 5 Humanized Anti-bcma Chimeric Antigen Receptor App 20190153061 - Brogdon; Jennifer ; et al. | 2019-05-23 |
| Regulatable chimeric antigen receptor Grant 10,287,354 - Brogdon , et al. | 2019-05-14 |
| Novel Rapamycin Derivatives App 20190092788 - BONAZZI; Simone ; et al. | 2019-03-28 |
| Treatment Of Cancer Using A Cd123 Chimeric Antigen Receptor App 20180312595 - Brogdon; Jennifer ; et al. | 2018-11-01 |
| Production of therapeutic proteins in genetically modified mammalian cells Grant 10,030,063 - Fornaro , et al. July 24, 2 | 2018-07-24 |
| Stabilized Insulin-like Growth Factor Polypeptides App 20170066808 - GLASS; David Jonathan ; et al. | 2017-03-09 |
| Regulatable Chimeric Antigen Receptor App 20160311907 - Brogdon; Jennifer ; et al. | 2016-10-27 |
| Insulin-like Growth Factor Mimetics For Use In Therapy App 20160271265 - FISCHBECK; Kenneth ; et al. | 2016-09-22 |
| Production Of Therapeutic Proteins In Genetically Modified Mammalian Cells App 20150322131 - FORNARO; Mara ; et al. | 2015-11-12 |
| Stabilized Insulin-like Growth Factor Polypeptides App 20140235538 - GLASS; David Jonathan ; et al. | 2014-08-21 |
| Stabilized insulin-like growth factor polypeptides Grant 8,722,621 - Glass , et al. May 13, 2 | 2014-05-13 |
| Stabilized Insulin-like Growth Factor Polypeptides App 20130059779 - GLASS; David Jonathan ; et al. | 2013-03-07 |
| Stabilized insulin-like growth factor polypeptides Grant 8,343,918 - Glass , et al. January 1, 2 | 2013-01-01 |
| Stabilized Insulin-like Growth Factor Polypeptides App 20100234290 - Glass; David Jonathan ; et al. | 2010-09-16 |
| Stabilized Insulin-like Growth Factor Polypeptides App 20100173839 - Glass; David Jonathan | 2010-07-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 